'Silent' carriage of two familial Mediterranean fever gene mutations in large families with only a single identified patient

Clinical Genetics

Volumn 82, Issue 3, 2012, Pages 288-291

  Camus, D ^a   Shinar, Y ^a   Aamar, S ^b   Langevitz, P ^a   Ben Zvi, I ^a   Livneh, A ^a   Lidar, M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

FMF; Phenotype III; Silent carriage

Indexed keywords

ARTICLE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

FAMILIAL MEDITERRANEAN FEVER; GENOTYPE; HUMANS; MUTATION; PHENOTYPE;

EID: 84865085470     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01785.x     Document Type: Article

References (16)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967: 43: 227-253.
2. Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 2007: 65: 318-324.
3. Gershoni-Baruch R, Brik R, Lidar M, Shinawi M, Livneh A. Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. J Rheumatol 2003: 30: 308-312.
4. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003: 48: 1149-1155.
5. Livneh A. Amyloidosis of familial Mediterranean fever (FMF)-insights to FMF phenotype II. Harefuah 2006: 145: 743-745, 782.
6. Kogan A, Shinar Y, Lidar M et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001: 102: 272-276.
7. Livneh A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997: 40: 1879-1885.
8. Zaks N, Shinar Y, Padeh S et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J 2003: 5: 585-588.
9. Aksentijevich I, Torosyan Y, Samuels J et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999: 64: 949-962.
10. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002: 10: 145-149.
11. Marek-Yagel D, Berkun Y, Padeh S et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum 2009: 60: 1862-1866.
12. Tchernitchko D, Moutereau S, Legendre M et al. MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum 2005: 52: 3603-3605.
13. Bernot A, da Silva C, Petit JL et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 1998: 7: 1317-1325.
14. Marek-Yagel D, Bar-Joseph I, Pras E, Berkun Y. Is E148Q a benign polymorphism or a disease-causing mutation? J Rheumatol 2009: 36: 2372.
15. Tchernitchko DO, Gerard-Blanluet M, Legendre M, Cazeneuve C, Grateau G, Amselem S. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis 2006: 65: 1154-1157.
16. Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 2001: 9: 634-637.